A kind of budesonide rectal thermosensitive gel and its preparation method and application
A temperature-sensitive gel, in-situ technology, applied in pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. Contamination of clothing and other problems, to achieve the effect of improving the convenience of medication, reducing the difficulty of medication, and preventing medication leakage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] prescription
[0030] Budesonide 0.002%
[0031] Hypromellose (bioadhesive) 1.002%
[0032] Poloxamer 407 (temperature-sensitive material) 18.19%
[0033] Poloxamer 188 (temperature regulator) 1.823%
[0034] Benzalkonium bromide (preservative) 0.02%
[0035] The rest is pH 4.5 aqueous solution (adjusted with 0.27% citric acid, 0.55% sodium citrate)
[0036] Preparation Process
[0037] a. Weigh the raw materials according to the prescription ratio;
[0038] b, boil pH 4.5 aqueous solution, cool;
[0039] c. Add benzalkonium bromide to the solution in step b, stir and dissolve completely, and then add hypromellose and poloxamer 188 in the same way;
[0040] d, adding budesonide to the solution in step c, stirring and mixing;
[0041] e. Add the poloxamer 407 temperature-sensitive material to the solution in step d, stir and wet it fully, add water to make up for the weight loss, and place it at 4°C until it swells completely.
Embodiment 2
[0043] prescription
[0044] Budesonide 0.002%
[0045] Hypromellose 0.923%
[0046] Poloxamer 407 18.308%
[0047] Poloxamer 188 2.001%
[0048] Benzalkonium Bromide 0.02%
[0049] The rest is pH 5.5 aqueous solution (adjusted with 0.029% citric acid, 0.20% sodium citrate)
[0050] Preparation Process:
[0051] a. Weigh the raw materials according to the prescription ratio;
[0052] b, boil pH 5.5 aqueous solution, cool;
[0053] c. Add benzalkonium bromide to the solution of step b, stir and dissolve completely, then add hypromellose and poloxamer 188 temperature regulator successively in the same way;
[0054] d, adding budesonide to the solution in step c, stirring and mixing;
[0055] e. Add the poloxamer 407 temperature-sensitive material to the solution in step d, stir and wet it fully, add water to make up for the weight loss, and place it at 4°C until it swells completely.
Embodiment 3
[0057] prescription
[0058] Budesonide 0.002%
[0059] Hypromellose 1.148%
[0060] Poloxamer 407 18.322%
[0061] Poloxamer 188 2.210%
[0062] Benzalkonium Bromide 0.02%
[0063] The rest is pH 6.8 aqueous solution (adjusted with 0.68% potassium dihydrogen phosphate concentration and 0.09% sodium hydroxide)
[0064] Preparation Process
[0065] a. Weigh the raw materials according to the prescription ratio;
[0066]b, boil pH 6.8 aqueous solution, cool;
[0067] c. Add benzalkonium bromide to the solution of step b, stir and dissolve completely, then add hypromellose and poloxamer 188 temperature regulator successively in the same way;
[0068] d, adding budesonide to the solution in step c, stirring and mixing;
[0069] e. Add the poloxamer 407 temperature-sensitive material to the solution in step d, stir and wet it fully, add water to make up for the weight loss, and place it at 4°C until it swells completely.
PUM
| Property | Measurement | Unit |
|---|---|---|
| phase transition temperature | aaaaa | aaaaa |
| phase transition temperature | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


